Editing the Genome to Cure Genetic Disease

Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer. Our aim: to transform the lives of patients and families affected by genetic disease.

Social Media

Our #MissionBay team joined @Bayer & other #CoLaborator companies to serve food at the @FamilyHouseSF - an amazing #nonprofit that provides temp #housing for families of #children being treated for #cancer & other serious illnesses @UCSFHospitals #volunteerday #MondayMotivations

Missed #LBRefresh Berlin? Check out our fireside chat with Peter of @casebiatx! #CRISPR #biotech https://t.co/brNNdzUyLD

See us on Twitter